AKT1 and differentiated thyroid carcinoma: Another study, conducted by Wang, Chai et al. found that TRIM26, acting as an inhibitor of the PI3K/Akt pathway, effectively suppressed Papillary Thyroid Carcinoma (PTC) (6).